Congressional leaders celebrated the restored $20 million in previously frozen HIV prevention funds and surveillance programs ...

The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, ...

In the heart of Chicago’s Lakeview neighborhood, the work to shore up healthcare carries on at Howard Brown Health. “We are a ...

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...

In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community ...

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

"We don't want to shut these doors, we want to make sure they stay open and we can help as many people as we can".

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...